HER2/Neu/cerbB2 Antagonists
- Name
- HER2/Neu/cerbB2 Antagonists
- Accession Number
- DBCAT004073
- Description
Not Available
- Drugs
Drug Drug Description Pertuzumab An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. Trastuzumab A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. - Drugs & Drug Targets
Drug Target Type Pertuzumab Receptor tyrosine-protein kinase erbB-2 target Trastuzumab Receptor tyrosine-protein kinase erbB-2 target